statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Bitcoin

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Invesco QQQ Trust Series 1

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

EXCLUSIVE: Adial Pharmaceuticals Moves Forward To Second Cohort In Pharmacokinetics Study of AD04 For Alcohol Use Disorder

Adial Pharmaceuticals progresses to the second cohort in the AD04 pharmacokinetics study for Alcohol Use Disorder. This study, involving up to 30 healthy volunteers, will provide critical insights...

EXCLUSIVE: Adial Pharmaceuticals Announces Publication In Journal Supporting the Potential Efficacy Of AD04 For Alcohol Use Disorder

Adial Pharmaceuticals publishes Phase 3 ONWARD study results in the European Journal of Internal Medicine. The study reveals AD04 significantly reduces heavy drinking days, with adverse events...

Why Bitcoin-Linked MicroStrategy Along With Adial Pharmaceuticals, Alpine Immune Sciences, Marin Software, And Tesla Are On Investors' Radars Today

On Wednesday, key U.S. stock indexes closed lower, as the Dow Jones Industrial Average fell by 1.1% to 38,461.51, the S&P 500 dropped nearly 1% to 5,160.64, and the Nasdaq ended the day down by 0.8...

12 acciones de salud en movimiento durante la preapertura del 10/04/2024

Acciones al alza
Jaguar Health (NASDAQ:JAGX) avanzaron un 43,99% para establecerse en los 0,13 d lares durante la sesi n del pre-market del mi rcoles.
Adial Pharmaceuticals (NASDAQ:ADIL) ganaron un...

Adial Pharmaceuticals Reports 2023 Fiscal Year Financial Results and Provides Business Update

Received Favorable Feedback from US and EU Regulatory Agencies Advancing Discussions with Potential Strategic Partners Received $4.3 Million in Gross Proceeds from Warrant Exercises Subsequent to...

Adial Pharmaceuticals reports FY results

Adial Pharmaceuticals reports FY results...

Adial Pharmaceuticals, Inc. (NASDAQ:ADIL) Short Interest Up 275.8% in March

Adial Pharmaceuticals, Inc. (NASDAQ:ADIL  Get Free Report) was the recipient of a significant increase in short interest in the month of March. As of March 15th, there was short interest...

Q1 2025 Earnings Estimate for Adial Pharmaceuticals, Inc. (NASDAQ:ADIL) Issued By Litchfield Hills Research

Adial Pharmaceuticals, Inc. (NASDAQ:ADIL  Free Report)  Equities researchers at Litchfield Hills Research issued their Q1 2025 EPS estimates for Adial Pharmaceuticals in a research note...

Litchfield Hills Research Weighs in on Adial Pharmaceuticals, Inc.'s Q1 2025 Earnings (NASDAQ:ADIL)

Adial Pharmaceuticals, Inc. (NASDAQ:ADIL  Free Report)  Litchfield Hills Research issued their Q1 2025 earnings estimates for shares of Adial Pharmaceuticals in a report released on...

Peering Into Adial Pharmaceuticals's Recent Short Interest

Adial Pharmaceuticals, Inc. engages in the development of therapeutics for the treatment or prevention of addiction and related disorders. It offers the AD04, a selective serotonin-3 antagonist. The company was founded by Bankole A. Johnson and William B. Stilley, III in November 2010 and is headquartered in Glen Allen, VA.

Volume	817,256.00
52-Wk High	$8.88
52-Wk Low	$0.765

ADIL Adial Pharmaceuticals Inc

About

Feed

News

Fundamentals